Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

In the statin era, how important are intense lifestyle changes?

Parmley WW.

J Am Coll Cardiol. 2003 Jan 15;41(2):273-4. No abstract available.

2.

[44. Normalizing blood lipids--with diet, sports and antilipemic agents].

Faust M, Krone W.

MMW Fortschr Med. 2003 May 8;145(19):I-X; quiz XI-XII. German. No abstract available.

PMID:
12813992
3.

Lipids and prevention in coronary care.

Betteridge DJ.

Trans Med Soc Lond. 1994-1995;111:43-58. No abstract available.

PMID:
9156156
4.

Management of dyslipidemia.

Akel MM, Salti I.

J Med Liban. 2001 Sep-Oct;49(5):274-8. No abstract available.

PMID:
12243421
5.

Clinical practice guidelines for the management of dyslipidemia.

Nichols N.

Can J Cardiovasc Nurs. 2004;14(2):7-10. Review.

PMID:
15230023
6.

The use of lipid-lowering agents in HIV-infected patients.

Meienberg F, Battegay E, Bucher HC, Battegay M.

J HIV Ther. 2001 May;6(2):40-4. Review. No abstract available.

PMID:
11501203
7.

[Significance of education for lifestyle modification in patients with hyperlipidemia].

Toyohara K, Kurisu A, Fukumoto T, Wada T.

Nihon Rinsho. 2001 Mar;59 Suppl 3:518-23. Review. Japanese. No abstract available.

PMID:
11347124
8.

[Statin treatment in type 2 diabetes. Is it a must today?].

Faust M.

MMW Fortschr Med. 2003 Feb 27;145(9):35-6. German. No abstract available.

PMID:
12666527
9.

Management of dyslipidemia in adults with diabetes. American Diabetes Association.

[No authors listed]

Diabetes Care. 1998 Jan;21(1):179-82. No abstract available.

PMID:
9538989
10.

Importance of hyperlipidaemia and therapy in renal patients.

Wanner C.

Nephrol Dial Transplant. 2000;15 Suppl 5:92-6. Review. No abstract available.

PMID:
11073280
11.
12.

NHF guidelines on the management of dyslipidaemia.

Mann J, Agnew T.

N Z Med J. 1996 Sep 13;109(1029):345. No abstract available.

PMID:
8862356
13.

[Treatment of dyslipidemia].

Cybulska B.

Pol Merkur Lekarski. 2002 Nov;13 Suppl 1:11-2. Polish. No abstract available.

PMID:
12621774
14.

The contribution of changes in diet, exercise, and stress management to changes in coronary risk in women and men in the multisite cardiac lifestyle intervention program.

Daubenmier JJ, Weidner G, Sumner MD, Mendell N, Merritt-Worden T, Studley J, Ornish D.

Ann Behav Med. 2007 Feb;33(1):57-68.

PMID:
17291171
15.

Statin therapy in nephrotic syndrome.

Chan NN.

J R Soc Med. 1999 Mar;92(3):158. No abstract available.

16.

[Hyperlipidemia with obesity].

Ueno M.

Nihon Rinsho. 2001 Mar;59 Suppl 3:728-32. Review. Japanese. No abstract available.

PMID:
11347162
17.

Management of hyperlipidaemia. Why, when and how to treat.

Oliver MF, Pyörälä K, Shepherd J.

Eur Heart J. 1997 Mar;18(3):371-5. Review. No abstract available.

PMID:
9076374
18.
19.

[Lifestyle-related diseases: Dyslipidemia].

Moriyama T.

Nihon Jinzo Gakkai Shi. 2005;47(1):8-16. Review. Japanese. No abstract available.

PMID:
15754758
20.

Prevention of coronary heart disease: a nonhormonal approach.

Lewis V, Hoeger K.

Semin Reprod Med. 2005 May;23(2):157-66. Review.

PMID:
15852201

Supplemental Content

Support Center